XLV vs. XBI
Compare and contrast key facts about State Street Health Care Select Sector SPDR ETF (XLV) and SPDR S&P Biotech ETF (XBI).
XLV and XBI are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XLV is a passively managed fund by State Street that tracks the performance of the Health Care Select Sector Index. It was launched on Dec 16, 1998. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006. Both XLV and XBI are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
XLV vs. XBI - Performance Comparison
Loading graphics...
XLV vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XLV State Street Health Care Select Sector SPDR ETF | -4.77% | 14.50% | 2.47% | 2.07% | -2.08% | 26.04% | 13.30% | 20.45% | 6.28% | 21.77% |
XBI SPDR S&P Biotech ETF | 5.77% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
Returns By Period
In the year-to-date period, XLV achieves a -4.77% return, which is significantly lower than XBI's 5.77% return. Both investments have delivered pretty close results over the past 10 years, with XLV having a 9.60% annualized return and XBI not far behind at 9.28%.
XLV
- 1D
- -0.62%
- 1M
- -5.95%
- YTD
- -4.77%
- 6M
- 3.39%
- 1Y
- 3.55%
- 3Y*
- 5.64%
- 5Y*
- 6.45%
- 10Y*
- 9.60%
XBI
- 1D
- 0.32%
- 1M
- 4.42%
- YTD
- 5.77%
- 6M
- 26.12%
- 1Y
- 60.61%
- 3Y*
- 18.94%
- 5Y*
- -1.10%
- 10Y*
- 9.28%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XLV vs. XBI - Expense Ratio Comparison
XLV has a 0.08% expense ratio, which is lower than XBI's 0.35% expense ratio.
Return for Risk
XLV vs. XBI — Risk / Return Rank
XLV
XBI
XLV vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR ETF (XLV) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XLV | XBI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.20 | 2.13 | -1.93 |
Sortino ratioReturn per unit of downside risk | 0.40 | 2.83 | -2.43 |
Omega ratioGain probability vs. loss probability | 1.05 | 1.36 | -0.31 |
Calmar ratioReturn relative to maximum drawdown | 0.39 | 4.90 | -4.51 |
Martin ratioReturn relative to average drawdown | 0.83 | 17.98 | -17.16 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XLV | XBI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.20 | 2.13 | -1.93 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.44 | -0.03 | +0.48 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.58 | 0.29 | +0.29 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.46 | 0.36 | +0.10 |
Correlation
The correlation between XLV and XBI is 0.63, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
XLV vs. XBI - Dividend Comparison
XLV's dividend yield for the trailing twelve months is around 1.71%, more than XBI's 0.34% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XLV State Street Health Care Select Sector SPDR ETF | 1.71% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
XBI SPDR S&P Biotech ETF | 0.34% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Drawdowns
XLV vs. XBI - Drawdown Comparison
The maximum XLV drawdown since its inception was -39.17%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for XLV and XBI.
Loading graphics...
Drawdown Indicators
| XLV | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.17% | -63.89% | +24.72% |
Max Drawdown (1Y)Largest decline over 1 year | -10.21% | -10.67% | +0.46% |
Max Drawdown (5Y)Largest decline over 5 years | -17.11% | -55.04% | +37.93% |
Max Drawdown (10Y)Largest decline over 10 years | -28.40% | -63.89% | +35.49% |
Current DrawdownCurrent decline from peak | -7.98% | -25.46% | +17.48% |
Average DrawdownAverage peak-to-trough decline | -7.12% | -20.91% | +13.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.13% | 3.65% | +1.48% |
Volatility
XLV vs. XBI - Volatility Comparison
The current volatility for State Street Health Care Select Sector SPDR ETF (XLV) is 4.77%, while SPDR S&P Biotech ETF (XBI) has a volatility of 11.09%. This indicates that XLV experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XLV | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.77% | 11.09% | -6.32% |
Volatility (6M)Calculated over the trailing 6-month period | 9.86% | 19.22% | -9.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.64% | 28.69% | -11.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.56% | 32.21% | -17.65% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.53% | 32.14% | -15.61% |